BioHarvest Sciences Inc. (CNVCF)
- Previous Close
5.30 - Open
5.28 - Bid 5.13 x 40000
- Ask 5.29 x 40000
- Day's Range
5.28 - 5.28 - 52 Week Range
0.00 - 7.38 - Volume
310 - Avg. Volume
1,828 - Market Cap (intraday)
91.49M - Beta (5Y Monthly) 1.48
- PE Ratio (TTM)
-- - EPS (TTM)
-1.26 - Earnings Date Nov 26, 2024 - Dec 2, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness products. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes. The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.
www.bioharvest.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: CNVCF
View More
Performance Overview: CNVCF
Trailing total returns as of 10/16/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CNVCF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CNVCF
View MoreValuation Measures
Market Cap
91.51M
Enterprise Value
96.73M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.50
Price/Book (mrq)
15.49
Enterprise Value/Revenue
5.06
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-84.84%
Return on Assets (ttm)
-25.83%
Return on Equity (ttm)
-5,955.96%
Revenue (ttm)
19.13M
Net Income Avi to Common (ttm)
-16.23M
Diluted EPS (ttm)
-1.26
Balance Sheet and Cash Flow
Total Cash (mrq)
5.17M
Total Debt/Equity (mrq)
155.00%
Levered Free Cash Flow (ttm)
-5.96M
Company Insights: CNVCF
CNVCF does not have Company Insights